Proactive London sits down with PLC's () chief commercial officer Maurice Treacy.
Treacy discusses how he became involved with and his ambitions for the firm's health data initiative.
''Many rare diseases aren't known or badly diagnosed ... but rare isn't rare''.
''Rare is 300 million people in the world, 30 million people in Europe, it's a huge market and untapped to some extent''.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...
FOR OUR FULL DISCLAIMER CLICK HERE